This B-cell immune response, also underlying IgA upregulation in peribronchiolar lymphoid follicles [93], probably relates to toxic and microbial exposures occurring in the COPD lung and could be considered as an attempt to compensate for local IgA deficiency, which is partly inhibited by CS [88]. Here, CD79A is linked to chronic obstructive pulmonary disease.